P. Koskinen

发表

Common Protective and Diverse Smooth Muscle Cell Effects of AAV-Mediated Angiopoietin-1 and -2 Expression in Rat Cardiac Allograft Vasculopathy

K. Alitalo, M. Keränen, R. Krebs, 2006, Circulation research.

Results Ang 2 and Tie 2 Immunoreactivity Is Induced in Capillaries and Postcapillary Venules of Cardiac Allografts

K. Alitalo, S. Ylä-Herttuala, A. Saaristo, 2003 .

Angiopoietin-1 Protects Against the Development of Cardiac Allograft Arteriosclerosis

K. Alitalo, S. Ylä-Herttuala, A. Saaristo, 2003, Circulation.

VEGFR-1 and -2 Regulate Inflammation, Myocardial Angiogenesis, and Arteriosclerosis in Chronically Rejecting Cardiac Allografts

K. Alitalo, D. Hicklin, L. Alhonen, 2007, Arteriosclerosis, thrombosis, and vascular biology.

Cardiac Rehabilitation After Cancer Therapy in Children and Young Adults

G. Laffel, K. Haapa, P. Kaitaniemi, 1993 .

Trends in use and costs of prescription medication in patients with type 1 diabetes: 9-year follow-up after kidney transplantation

Raija Lithovius, Valma Harjutsalo, Carol Forsblom, 2013 .

Differential Effects of Pharmacological HIF Preconditioning of Donors Versus Recipients in Rat Cardiac Allografts

S. Syrjälä, M. Keränen, R. Krebs, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

BK virus viremia in a well‐HLA‐matched kidney transplant population mainly on low‐dose cyclosporine‐based immunosuppression

K. Salmela, E. Auvinen, L. Mannonen, 2012, Clinical transplantation.

Triple drug immunosuppression significantly reduces aortic allograft arteriosclerosis in the rat.

K. Lemström, A. Räisänen‐Sokolowski, P. Koskinen, 1996, Arteriosclerosis, thrombosis, and vascular biology.

Chronic Allograft Rejection

T. Paavonen, H. Isoniemi, A. Mennander, 1993 .

Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection.

M. Daemen, K. Lemström, L. Krogerus, 1995, Circulation.

Cytomegalovirus infection accelerates cardiac allograft vasculopathy: correlation between angiographic and endomyocardial biopsy findings in heart transplant patients

M. Nieminen, K. Lemström, L. Krogerus, 1993, Transplant international : official journal of the European Society for Organ Transplantation.

Employment of patients receiving maintenance dialysis and after kidney transplant: a cross-sectional study from Finland.

P. Finne, C. Grönhagen-Riska, P. Koskinen, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Prospective follow-up of primary CMV infections after 6 months of valganciclovir prophylaxis in renal transplant recipients.

P. Koskinen, I. Helanterä, I. Lautenschlager, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Effect of graft preservation and acute rejection on hypoxia-inducible factor-1 in rat cardiac allografts.

M. Keränen, R. Krebs, R. Tuuminen, 2006, Transplantation proceedings.

Early short-term imatinib treatment is sufficient to prevent the development of chronic allograft nephropathy.

P. Koskinen, J. Rintala, J. Savikko, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Role of platelet-derived growth factor and vascular endothelial growth factor in obliterative airway disease.

J. Wood, A. Nykänen, K. Lemström, 2006, American journal of respiratory and critical care medicine.

Predictors of renal allograft histologic damage progression.

K. Salmela, T. Paavonen, P. Finne, 2005, Journal of the American Society of Nephrology : JASN.

Intensive Perioperative Simvastatin Treatment Protects from Chronic Kidney Allograft Injury

P. Koskinen, J. Rintala, J. Savikko, 2015, American Journal of Nephrology.

Sirolimus inhibits lymphangiogenesis in rat renal allografts, a novel mechanism to prevent chronic kidney allograft injury

P. Koskinen, J. Savikko, Niina K. Palin, 2013, Transplant international : official journal of the European Society for Organ Transplantation.

Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. A possible linkage with enhanced allograft arteriosclerosis.

K. Lemström, C. Bruggeman, P. Koskinen, 1994, The American journal of pathology.

Prophylaxis in the Rat

J. Bruning, C. Bruggeman, P. Koskinen, 2005 .

CMV infection and allograft rejection.

K. Lemström, P. Koskinen, J. Tikkanen, 1998, Transplantation proceedings.

Cytomegalovirus infection-enhanced cardiac allograft vasculopathy is abolished by DHPG prophylaxis in the rat.

K. Lemström, C. Bruggeman, P. Koskinen, 1997, Circulation.

Cytomegalovirus infection-associated generalized immune activation in heart allograft recipients: a study of cellular events in peripheral blood and endomyocardial biopsy specimens

M. Nieminen, L. Krogerus, P. Koskinen, 1994, Transplant International.

Crosstalk of endothelin-1 and platelet-derived growth factor in cardiac allograft arteriosclerosis.

V. Pulkkinen, K. Lemström, P. Koskinen, 2002, Journal of the American College of Cardiology.

Inhibition of Tumor Necrosis Factor-α Attenuates Myocardial Remodeling in Rat Cardiac Allografts

V. Pulkkinen, K. Lemström, P. Koskinen, 2006 .

PDGF-A, -C, and -D but not PDGF-B Increase TGF-&bgr;1 and Chronic Rejection in Rat Cardiac Allografts

K. Alitalo, M. Keränen, R. Krebs, 2009, Arteriosclerosis, thrombosis, and vascular biology.

Targeting Lymphatic Vessel Activation and CCL21 Production by Vascular Endothelial Growth Factor Receptor-3 Inhibition Has Novel Immunomodulatory and Antiarteriosclerotic Effects in Cardiac Allografts

K. Alitalo, Yan Wu, S. Ylä-Herttuala, 2010, Circulation.

Role of nitric oxide in experimental obliterative bronchiolitis (chronic rejection) in the rat.

E. Aavik, K. Vaali, P. Koskinen, 1997, The Journal of clinical investigation.

THE CORRELATION BETWEEN SYMPTOMATIC CMV INFECTION AND CMV ANTIGENEMIA IN HEART ALLOGRAFT RECIPIENTS

M. Nieminen, P. Koskinen, P. Häyry, 1993, Transplantation.

Role of Endogenous Endothelin‐1 in Transplant Obliterative Airway Disease in the Rat

K. Lemström, P. Koskinen, J. Tikkanen, 2004, American Journal of Transplantation.

Tacrolimus treatment effectively inhibits progression of obliterative airway disease even at later stages of disease development.

A. Nykänen, K. Lemström, P. Koskinen, 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

DUAL ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN EXPERIMENTAL OBLITERATIVE BRONCHIOLITIS

R. Krebs, A. Nykänen, K. Lemström, 2004, American journal of respiratory and critical care medicine.

Platelet-derived growth factor regulates cytomegalovirus infection-enhanced obliterative bronchiolitis in rat tracheal allografts

R. Krebs, K. Lemström, C. Bruggeman, 2004, Transplantation.

Blockade of complement inhibits obliterative bronchiolitis in rat tracheal allografts.

U. Ryan, K. Lemström, P. Koskinen, 2000, American journal of respiratory and critical care medicine.

Role of platelet-derived growth factor in obliterative bronchiolitis (chronic rejection) in the rat.

E. Buchdunger, K. Lemström, E. Aavik, 1999, American journal of respiratory and critical care medicine.

Cytomegalovirus infection enhances experimental obliterative bronchiolitis in rat tracheal allografts.

K. Lemström, C. Bruggeman, P. Koskinen, 1997, American journal of respiratory and critical care medicine.

A dose-dependent inhibitory effect of cyclosporine A on obliterative bronchiolitis of rat tracheal allografts.

R. Krebs, K. Lemström, P. Koskinen, 1997, American journal of respiratory and critical care medicine.

Cytomegalovirus infection accelerates obliterative bronchiolitis of rat tracheal allografts

R. Krebs, K. Lemström, C. Bruggeman, 1996, Transplant international : official journal of the European Society for Organ Transplantation.

Bronchoscopy in the diagnosis and surveillance of respiratory infections in lung and heart–lung transplant recipients

V. Anttila, J. Lehto, K. Lemström, 2005, Transplant international : official journal of the European Society for Organ Transplantation.

Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts.

M. Nieminen, K. Lemström, L. Krogerus, 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

DUAL ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN EXPERIMENTAL OBLITERATIVE BRONCHIOLITIS

R. Krebs, A. Nykänen, K. Lemström, 2004, American journal of respiratory and critical care medicine.

Inhibition of tumor necrosis factor-alpha attenuates myocardial remodeling in rat cardiac allografts.

V. Pulkkinen, K. Lemström, P. Koskinen, 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Inhibition of tumor necrosis factor-alpha does not prevent cardiac allograft arteriosclerosis in the rat.

V. Pulkkinen, K. Lemström, P. Koskinen, 2001, Transplantation Proceedings.

How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts.

K. Lemström, P. Koskinen, P. Häyry, 1995, The American journal of pathology.

Cytological monitoring of peripheral blood, bronchoalveolar lavage fluid, and transbronchial biopsy specimens during acute rejection and cytomegalovirus infection in lung and heart–lung allograft recipients

K. Lemström, E. Taskinen, S. Pakkala, 2001, Clinical transplantation.

Is Cystatin C more sensitive than creatinine in detecting early chronic allograft nephropathy?

T. Paavonen, A. Harmoinen, P. Koskinen, 2008, Clinical nephrology.

Vascular endothelial growth factor plays a major role in development of experimental obliterative bronchiolitis.

D. Hicklin, R. Krebs, K. Lemström, 2006, Transplantation proceedings.

Combined Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor Inhibition in Rat Cardiac Allografts: Beneficial Effects on Inflammation and Smooth Muscle Cell Proliferation

J. Wood, R. Krebs, A. Nykänen, 2005, Transplantation.

A randomized, controlled trial comparing the immunogenecity and safety of a 23‐valent pneumococcal polysaccharide vaccination to a repeated dose 13‐valent pneumococcal conjugate vaccination in kidney transplant recipients

V. Anttila, H. Mäkisalo, H. Käyhty, 2020, Transplant infectious disease : an official journal of the Transplantation Society.

Cytomegalovirus infection‐associated generalized immune activation in heart allograft recipients: a study of cellular events in peripheral blood and endomyocardial biopsy specimens

M. Nieminen, L. Krogerus, P. Koskinen, 1994 .

Sterile Leukocyturia Is Associated With Interstitial Fibrosis and Tubular Atrophy in Kidney Allograft Protocol Biopsies

J. Torras, J. Cruzado, O. Bestard, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Pretransplant Dialysis Duration and Risk of Death After Kidney Transplantation in the Current Era

K. Salmela, P. Finne, P. Koskinen, 2014, Transplantation.

Primary CMV Infections Are Common in Kidney Transplant Recipients After 6 Months Valganciclovir Prophylaxis

K. Salmela, P. Koskinen, L. Kyllönen, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Polyomavirus BK and JC infections in well matched Finnish kidney transplant recipients

E. Auvinen, M. Lappalainen, A. Räisänen‐Sokolowski, 2009, Transplant International.

Timing and value of protocol biopsies in well‐matched kidney transplant recipients – a clinical and histopathologic analysis

H. Helin, A. Räisänen‐Sokolowski, P. Koskinen, 2007, Transplant international : official journal of the European Society for Organ Transplantation.

Cytomegalovirus infection induces vascular wall inflammation and doubles arteriosclerotic changes in rat cardiac allografts.

M. Daemen, K. Lemström, C. Bruggeman, 1995, Transplantation proceedings.

PDGF receptor inhibition prevents cardiac allograft arteriosclerosis in cholesterol-fed rabbits.

E. Buchdunger, K. Lemström, P. Koskinen, 2001, Transplantation proceedings.

Blockade of CD28/B7-2 costimulation inhibits experimental obliterative bronchiolitis in rat tracheal allografts: suppression of helper T cell type1-dominated immune response.

K. Lemström, P. Koskinen, J. Tikkanen, 2002, American journal of respiratory and critical care medicine.

Cytomegalovirus infection accelerates experimental obliterative bronchiolitis via platelet-derived growth factor upregulation.

K. Lemström, C. Bruggeman, P. Koskinen, 1997, Transplantation proceedings.

Effect of CMV Infection on Chronic Rejection of Kidney Transplants

L. Krogerus, J. Kloover, C. Bruggeman, 2003 .

Viral impact on long-term kidney graft function.

H. Hirsch, A. Egli, P. Koskinen, 2010, Infectious disease clinics of North America.

Chronic Allograft Damage Index (CADI) as a Biomarker in Kidney Transplantation

P. Koskinen, F. Ortiz, I. Helanterä, 2015 .

MAST CELLS IN ACUTE AND CHRONIC REJECTION OF RAT CARDIAC ALLOGRAFTS—A MAJOR SOURCE OF BASIC FIBROBLAST GROWTH FACTOR1

P. Kovanen, K. Lemström, K. Lindstedt, 2001, Transplantation.

CD28-B7-2 but not CD28-B7-1 interaction is required for T cell costimulation in experimental obliterative bronchiolitis in the rat.

K. Lemström, P. Koskinen, J. Tikkanen, 2001, Transplantation proceedings.

Decreased expression of vascular endothelial growth factor in idiopathic membranous glomerulonephritis: relationships to clinical course.

M. Ruutu, A. Teppo, P. Koskinen, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Vascular endothelial growth factor in chronic rat allograft nephropathy.

T. Paavonen, A. Nykänen, K. Lemström, 2008, Transplant immunology.

Joint Effects of Serum Triglyceride and LDL Cholesterol and HDL Cholesterol Concentrations on Coronary Heart Disease Risk in the Helsinki Heart Study

L. Tenkanen, P. Koskinen, Manninen, 1992 .

The risk of cytomegalovirus recurrence after kidney transplantation

P. Koskinen, I. Helanterä, I. Lautenschlager, 2011, Transplant international : official journal of the European Society for Organ Transplantation.

Detailed analysis of cell profiles in peripheral blood, bronchoalveolar lavage fluid, and transbronchial biopsy specimens during acute rejection and CMV infection in lung and heart-lung allograft recipients.

K. Lemström, E. Taskinen, S. Pakkala, 1999, Transplantation proceedings.

A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre‐emptive therapy in thoracic organ transplant recipients

M. Lappalainen, J. Lommi, J. Lehto, 2005, Transplant international : official journal of the European Society for Organ Transplantation.

Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients

M. Lappalainen, H. Piiparinen, P. Koskinen, 2005, Journal of medical virology.

Persistent cytomegalovirus infection is associated with increased expression of TGF-beta1, PDGF-AA and ICAM-1 and arterial intimal thickening in kidney allografts.

P. Koskinen, R. Loginov, I. Helanterä, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression.

K. Lemström, Serdar Yilmaz, C. Bruggeman, 1996, Kidney international.

Impact of glucose metabolism abnormalities on histopathological changes in kidney transplant protocol biopsies

A. Räisänen‐Sokolowski, P. Koskinen, F. Ortiz, 2010, Transplant international : official journal of the European Society for Organ Transplantation.

Immunobiology of Chronic Cardiac Allograft Rejection

K. Lemström, P. Koskinen, J. Tikkanen, 2001 .

Cytomegalovirus infection and cardiac allograft vasculopathy

K. Lemström, P. Koskinen, J. Tikkanen, 1999, Transplant infectious disease : an official journal of the Transplantation Society.

Rat cytomegalovirus infection and chronic kidney allograft rejection

K. Lemström, C. Bruggeman, P. Koskinen, 1996, Transplant international : official journal of the European Society for Organ Transplantation.

Prevention of cytomegalovirus infection-enhanced experimental obliterative bronchiolitis by antiviral prophylaxis or immunosuppression in rat tracheal allografts.

K. Lemström, C. Bruggeman, P. Koskinen, 2001, American journal of respiratory and critical care medicine.

Oral Platelet-Derived Growth Factor and Vascular Endothelial Growth Factor Inhibitor Sunitinib Prevents Chronic Allograft Injury in Experimental Kidney Transplantation Model

P. Koskinen, J. Rintala, J. Savikko, 2016, Transplantation.

Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survival

K. Salmela, P. Finne, P. Koskinen, 2006, Transplant international : official journal of the European Society for Organ Transplantation.

The impact of cytomegalovirus infections and acute rejection episodes on the development of vascular changes in 6-month protocol biopsy specimens of cadaveric kidney allograft recipients1

P. Koskinen, R. Loginov, I. Lautenschlager, 2003, Transplantation.

Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat.

K. Lemström, C. Bruggeman, P. Koskinen, 1994, Circulation.

Cytomegalovirus infection accelerates cardiac allograft vasculopathy: correlation between angiographic and endomyocardial biopsy findings in heart transplant patients

M. Nieminen, K. Lemström, L. Krogerus, 1993, Transplant international : official journal of the European Society for Organ Transplantation.

Molecular mechanisms of chronic renal allograft rejection.

K. Lemström, P. Koskinen, P. Häyry, 1995, Kidney international. Supplement.

Expression and localization of platelet-derived growth factor ligand and receptor protein during acute and chronic rejection of rat cardiac allografts.

K. Lemström, P. Koskinen, 1997, Circulation.

TGF-β1 Expression in Kidney Allograft Protocol Biopsies during Cyclosporine: a Therapy

A. Räisänen‐Sokolowski, P. Koskinen, E. Honkanen, 2013, International Journal of Artificial Organs.

Current characteristics and outcome of cytomegalovirus infections after kidney transplantation

K. Salmela, P. Reinke, C. Hinrichs, 2014, Transplant infectious disease : an official journal of the Transplantation Society.

Prevention of cardiac allograft arteriosclerosis by protein tyrosine kinase inhibitor selective for platelet-derived growth factor receptor.

E. Buchdunger, M. Myllärniemi, K. Lemström, 1999, Circulation.

Adhesion molecule P-selectin and vascular cell adhesion molecule-1 in enhanced heart allograft arteriosclerosis in the rat.

K. Lemström, P. Koskinen, Petri Koskinen, 1997, Circulation.

Role of angiogenic growth factors in transplant coronary artery disease

R. Krebs, A. Nykänen, K. Lemström, 2004, Annals of medicine.

Vascular Endothelial Growth Factor Enhances Cardiac Allograft Arteriosclerosis

J. Wood, K. Alitalo, S. Ylä-Herttuala, 2002, Circulation.

Quantitation of cytomegalovirus infection-associated histologic findings in endomyocardial biopsies of heart allografts.

M. Nieminen, L. Krogerus, P. Koskinen, 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Induction of adhesion molecules on the endothelia of rejecting cardiac allografts.

K. Lemström, P. Koskinen, P. Häyry, 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Endothelin-1 is biologically active in experimental rat obliterative bronchiolitis.

V. Pulkkinen, K. Lemström, P. Koskinen, 2001, Transplantation proceedings.

Inhibition of obliterative bronchiolitis by platelet-derived growth factor receptor protein-tyrosine kinase inhibitor.

E. Buchdunger, K. Lemström, P. Koskinen, 1999, Transplantation proceedings.

Inhibition of complement reduces obliterative bronchiolitis.

U. Ryan, K. Lemström, P. Koskinen, 1999, Transplantation proceedings.

The association of the induction of vascular cell adhesion molecule-1 with cytomegalovirus antigenemia in human heart allografts.

P. Koskinen, Petri Koskinen, 1993, Transplantation.

H. Sintonen, P. Finne, P. Koskinen, 2014, Transplant international : official journal of the European Society for Organ Transplantation.

Evolution of heart rate variability in cardiac transplant recipients: a clinical study

M. Kupari, P. Koskinen, P. Koskinen, 1996, Journal of internal medicine.

Frequency of infections and their relation to episodes of acute rejection among heart allograft recipients.

M. Nieminen, K. Lemström, L. Krogerus, 1994, Presse medicale.

Platelet-derived growth factor receptor inhibition reduces allograft arteriosclerosis of heart and aorta in cholesterol-fed rabbits

E. Buchdunger, R. Krebs, K. Lemström, 2003, Transplantation.

Expression of platelet-derived growth factor in the development of cardiac allograft vasculopathy in the rat.

K. Lemström, P. Koskinen, R. Sihvola, 1997, Transplantation proceedings.

Problem of chronic rejection.

K. Lemström, E. Aavik, P. Koskinen, 1988 .

Prevention of cardiac allograft arteriosclerosis by protein-tyrosine kinase inhibitor selective for platelet-derived growth factor receptor.

E. Buchdunger, M. Myllärniemi, K. Lemström, 1999, Transplantation proceedings.

Cytomegalovirus infection associated accelerated heart allograft arteriosclerosis may impair the late function of the graft.

M. Nieminen, K. Lemström, P. Koskinen, 1996, Clinical transplantation.

The effect of platelet-derived growth factor ligands in rat cardiac allograft vasculopathy and fibrosis.

K. Alitalo, M. Keränen, R. Krebs, 2006, Transplantation proceedings.

Cytomegalovirus-induced allograft vascular disease

V. Pulkkinen, K. Lemström, P. Koskinen, 2000 .

IgA nephropathy recurs early in the graft when assessed by protocol biopsy.

J. Grinyó, J. Cruzado, A. Räisänen‐Sokolowski, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Effect of Cytomegalovirus on Cardiac Allograft Arteriosclerosis—Indirect or Direct?

K. Lemström, P. Koskinen, J. Tikkanen, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The role of cytomegalovirus infection in chronic allograft nephropathy.

P. Koskinen, R. Loginov, I. Helanterä, 2005, Transplantation.

Increased urinary excretion of transforming growth factor-beta(1) in renal transplant recipients during cytomegalovirus infection.

A. Teppo, P. Koskinen, I. Helanterä, 2006, Transplant immunology.

Triple-drug immunosuppression significantly reduces chronic rejection in noninfected and RCMV-infected rats.

K. Lemström, C. Bruggeman, P. Koskinen, 1994, Transplantation proceedings.

Demonstration of HHV‐6 antigens in biopsies of kidney transplant recipients with cytomegalovirus infection

P. Koskinen, R. Loginov, I. Helanterä, 2008, Transplant international : official journal of the European Society for Organ Transplantation.

MONOTHERAPY WITH EVEROLIMUS OR FTY720 AMELIORATES CHRONIC ALLOGRAFT NEPHROPATHY (CAN) AT LATE STAGES, WHILE THE COMBINATION WITH CYCLOSPORINE DOES NOT TREAT CAN

D. Hicklin, Yan Wu, U. Heemann, 2006 .

Electrocardiographic changes before and after successful kidney transplantation and associations with cardiovascular and mortality outcomes

P. Groop, K. Nikus, M. Eskola, 2018, Clinical Transplantation.

Immunobiology and pathology of chronic rejection.

M. Myllärniemi, K. Lemström, A. Räisänen‐Sokolowski, 1997, Transplantation proceedings.

Chronic rejection: potential new sites of therapy.

M. Myllärniemi, K. Lemström, E. Aavik, 1996, Transplantation proceedings.

Angiogenic Growth Factors in Cardiac Allograft Rejection

M. Keränen, R. Krebs, R. Tuuminen, 2006, Transplantation.

Association of immune cell function assay with protocol biopsy findings and viral infections in well matched kidney transplant recipients.

P. Koskinen, I. Helanterä, 2010, Clinical nephrology.

Effect of Severe Renal Failure and Haemodialysis on the Pharmacokinetics of Levosimendan and Its Metabolites

P. Pentikäinen, V. Harjola, P. Koskinen, 2007, Clinical pharmacokinetics.

Epidermal growth factor receptor inhibition by erlotinib prevents vascular smooth muscle cell and monocyte-macrophage function in vitro.

P. Koskinen, J. Rintala, J. Savikko, 2015, Transplant immunology.

Epidermal growth factor receptor inhibition with erlotinib ameliorates anti-Thy 1.1-induced experimental glomerulonephritis

P. Koskinen, J. Rintala, J. Savikko, 2016, Journal of Nephrology.

Epidermal Growth Factor Inhibition, a Novel Pathway to Prevent Chronic Allograft Injury

P. Koskinen, J. Rintala, J. Savikko, 2014, Transplantation.